Clear, concise and well worth a second read! Bravo AP !What does pizza sauce or money losing pizza restaurants have to do with Dialco? We have 2 FDA approvals for very unique machines (have a look at the presentations on the Spectral site). We are moving towards getting DIMI approved for home use. As for the share issue they drove the price from around $0.80 per share to do the issue at $.60 per share. Since then someone is manipulating the price well below the $0.60. If you have evidence the institutions that bought are selling please share. I doubt they are.
Paradigm gave Dialco a value of $150 mill in February before the last FDA approval of DIMI. That's $0.60 per share Spectral share for Dialco on it's own before the approval. Outset Medical is worth $2 billion USD and their Tablo machines arguably are not as versatile as Dialco's machines. On an equivalent basis Dialco would be worth $10 Cdn per Spectral share. Similarly look at NxStage. The recent conference and COVID suggest that approved CRRT's are valuable and there's a CRRT shortage. So we have the goods. You decide where your opinion on Dialco's value is. I know where mine is.
Our management is not doing anything (on the surface anyway) to sell machines or promote Dialco. I think all shareholders share that opinion. So on Dec 4 grill them about their lack of effort.